These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Effectiveness and safety of antiviral therapy of military personnel suffering from chronic hepatitis C].
    Author: Zhdanov KV, Gusev DA, Kozlov KV, Shishkin MK, Sukachev VS, Shakhmanov DM, Zhabrov SS.
    Journal: Voen Med Zh; 2015 Apr; 336(4):44-9. PubMed ID: 26454938.
    Abstract:
    In order to evaluate effectiveness and safety of antiviral therapy schemes examined and treated 191 patients with chronic bepatitis C were assigned standard interferon and ribavirin, pegslated interferon and ribavirin, the total duration of the course coput 24-48 weeks. Based on clinical and laboratory parameters evaluated the safety of antiviral therapy. Formation of sustainable viral response, depending on the genotype observed, was given at 58,9-70%.of patients. In case of insufficient. antiviral therapy was prescribed a second course that will improve the effectiveness of treatment to 90-95%. Correction of adverse events was held lower dosages of interferon and/or ribavirin.
    [Abstract] [Full Text] [Related] [New Search]